LT2601214T - Vegf antagonistų kompozicijos ir jų panaudojimas - Google Patents
Vegf antagonistų kompozicijos ir jų panaudojimasInfo
- Publication number
- LT2601214T LT2601214T LTEP11745870.3T LT11745870T LT2601214T LT 2601214 T LT2601214 T LT 2601214T LT 11745870 T LT11745870 T LT 11745870T LT 2601214 T LT2601214 T LT 2601214T
- Authority
- LT
- Lithuania
- Prior art keywords
- vegf antagonist
- antagonist compositions
- compositions
- vegf
- antagonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/10—Protein-tyrosine kinases (2.7.10)
- C12Y207/10001—Receptor protein-tyrosine kinase (2.7.10.1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37154610P | 2010-08-06 | 2010-08-06 | |
| PCT/US2011/046802 WO2012019128A1 (en) | 2010-08-06 | 2011-08-05 | Vegf antagonist compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT2601214T true LT2601214T (lt) | 2018-02-26 |
Family
ID=44630479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP11745870.3T LT2601214T (lt) | 2010-08-06 | 2011-08-05 | Vegf antagonistų kompozicijos ir jų panaudojimas |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9441029B2 (lt) |
| EP (2) | EP3327032A1 (lt) |
| CY (1) | CY1121111T1 (lt) |
| DK (1) | DK2601214T3 (lt) |
| ES (1) | ES2652508T3 (lt) |
| HR (1) | HRP20180154T1 (lt) |
| HU (1) | HUE035554T2 (lt) |
| LT (1) | LT2601214T (lt) |
| PL (1) | PL2601214T3 (lt) |
| PT (1) | PT2601214T (lt) |
| SI (1) | SI2601214T1 (lt) |
| WO (1) | WO2012019128A1 (lt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3377101A4 (en) * | 2015-11-19 | 2019-08-07 | Zhuhai Tairuishang Biopharm Ltd. | VEGF BINDING METHODS AND COMPOSITIONS |
| AU2019212622A1 (en) | 2018-01-26 | 2020-08-13 | The Regents Of The University Of California | Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents |
| IL293131A (en) | 2019-11-25 | 2022-07-01 | Univ California | Long-acting vegf inhibitors for intraocular neovascularization |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5336603A (en) | 1987-10-02 | 1994-08-09 | Genentech, Inc. | CD4 adheson variants |
| US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
| DE68926888T2 (de) | 1988-01-22 | 1997-01-09 | Zymogenetics Inc | Verfahren zur Herstellung von sekretierten Rezeptoranalogen |
| US5567584A (en) | 1988-01-22 | 1996-10-22 | Zymogenetics, Inc. | Methods of using biologically active dimerized polypeptide fusions to detect PDGF |
| US5116964A (en) | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| JPH03233530A (ja) | 1990-02-09 | 1991-10-17 | Fuji Photo Optical Co Ltd | カメラ |
| US20020032313A1 (en) | 1991-03-29 | 2002-03-14 | Genentech, Inc. | Vascular endothelial cell growth factor antagonists |
| BR9207175A (pt) | 1992-10-28 | 1995-12-12 | Genentech Inc | Composição contendo antagonista de fator de crescimento de célula endotelial vascular sequência aminoácida de anticorpo monoclonal polipeptídeo e método de tratamento de tumor em mamífero |
| FR2702152B1 (fr) | 1993-03-03 | 1995-05-24 | Inst Nat Sante Rech Med | Virus recombinants et leur utilisation en thérapie génique. |
| CA2158745C (en) | 1993-03-25 | 2007-06-19 | Richard L. Kendall | Inhibitor of vascular endothelial cell growth factor |
| US6686200B1 (en) | 1993-08-31 | 2004-02-03 | Uab Research Foundation | Methods and compositions for the large scale production of recombinant adeno-associated virus |
| US5827702A (en) | 1994-10-31 | 1998-10-27 | Genentech, Inc. | Ocular gene therapy |
| JPH09154588A (ja) | 1995-10-07 | 1997-06-17 | Toagosei Co Ltd | Ｖｅｇｆ結合性ポリペプチド |
| US6100071A (en) | 1996-05-07 | 2000-08-08 | Genentech, Inc. | Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
| DE69736860T2 (de) | 1996-09-24 | 2007-05-16 | Merck & Co., Inc. | Verbindungen zur hemmung der angiogenese durch gentherapie |
| WO1998031794A1 (fr) | 1997-01-17 | 1998-07-23 | Toa Gosei Co., Ltd. | Polypeptide liant le facteur vegf |
| AU7383298A (en) | 1997-05-13 | 1998-12-08 | Regents Of The University Of California, The | Novel antiangiogenic peptide agents and their therapeutic and diagnostic use |
| ATE312935T1 (de) | 1997-06-03 | 2005-12-15 | Regulatorische sequenzen für die in-vivo- expression einer heterologen dns-sequenz in endothelzellen und ihre verwendungen. | |
| ATE371727T1 (de) | 1997-06-18 | 2007-09-15 | Merck & Co Inc | Kdr, ein menschlicher tyrosin kinase rezeptor |
| AU9319198A (en) | 1997-09-19 | 1999-04-05 | Trustees Of The University Of Pennsylvania, The | Methods and vector constructs useful for production of recombinant aav |
| US6378526B1 (en) | 1998-08-03 | 2002-04-30 | Insite Vision, Incorporated | Methods of ophthalmic administration |
| US7083950B2 (en) | 1998-09-25 | 2006-08-01 | Regeneron Pharmaceuticals, Inc. | High affinity fusion proteins and therapeutic and diagnostic methods for use |
| US20020102208A1 (en) | 1999-03-01 | 2002-08-01 | Paul Chinn | Radiolabeling kit and binding assay |
| US6943153B1 (en) | 1999-03-15 | 2005-09-13 | The Regents Of The University Of California | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| AU3755900A (en) | 1999-03-15 | 2000-10-04 | Chiron Corporation | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| CA2376379C (en) | 1999-06-08 | 2007-08-07 | Regeneron Pharmaceuticals, Inc. | Modified chimeric polypeptides with improved pharmacokinetic properties |
| US7070959B1 (en) | 1999-06-08 | 2006-07-04 | Regeneron Pharmaceuticals, Inc. | Modified chimeric polypeptides with improved pharmacokinetic properties |
| US7087411B2 (en) | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
| US6821775B1 (en) | 2000-02-11 | 2004-11-23 | Genvec, Inc. | Viral vector encoding pigment epithelium-derived factor |
| WO2002024234A2 (en) | 2000-09-20 | 2002-03-28 | The Regents Of The University Of California | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| CZ20031927A3 (cs) | 2001-01-09 | 2003-10-15 | Merck Patent Gmbh | Farmaceutický prostředek na bázi inhibitorů receptoru tyrosinkinázy a inhibitorů angiogeneze |
| US20060193830A1 (en) | 2002-03-20 | 2006-08-31 | Hauswirth William W | Raav vector compositions and methods for the treatment of choroidal neovascularization |
| CU23178A1 (es) | 2002-04-15 | 2006-09-22 | Ct Ingenieria Genetica Biotech | INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA |
| MXPA04012496A (es) | 2002-06-21 | 2005-09-12 | Novo Nordisk Healthcare Ag | Glicoformos del factor vii pegilados. |
| ES2327409T3 (es) | 2003-03-26 | 2009-10-29 | Apogenix Gmbh | Proteinas de fusion fc mejoradas. |
| US20060198819A1 (en) | 2003-08-08 | 2006-09-07 | Novo Nordisk Healthcare A/G | Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest |
| EP1804835B9 (en) * | 2004-09-13 | 2012-05-02 | Genzyme Corporation | Multimeric constructs |
| NZ555286A (en) | 2004-12-17 | 2010-04-30 | Genentech Inc | Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy |
| WO2010019263A2 (en) * | 2008-08-15 | 2010-02-18 | Genzyme Corporation | Soluble flt constructs for treating cancers |
-
2011
- 2011-08-05 ES ES11745870.3T patent/ES2652508T3/es active Active
- 2011-08-05 PL PL11745870T patent/PL2601214T3/pl unknown
- 2011-08-05 HU HUE11745870A patent/HUE035554T2/en unknown
- 2011-08-05 SI SI201131407T patent/SI2601214T1/en unknown
- 2011-08-05 PT PT117458703T patent/PT2601214T/pt unknown
- 2011-08-05 EP EP17198701.9A patent/EP3327032A1/en active Pending
- 2011-08-05 US US13/814,182 patent/US9441029B2/en active Active
- 2011-08-05 EP EP11745870.3A patent/EP2601214B1/en active Active
- 2011-08-05 WO PCT/US2011/046802 patent/WO2012019128A1/en active Application Filing
- 2011-08-05 DK DK11745870.3T patent/DK2601214T3/en active
- 2011-08-05 LT LTEP11745870.3T patent/LT2601214T/lt unknown
-
2016
- 2016-07-25 US US15/218,667 patent/US10308917B2/en active Active
-
2018
- 2018-01-26 HR HRP20180154TT patent/HRP20180154T1/hr unknown
- 2018-01-31 CY CY181100113T patent/CY1121111T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10308917B2 (en) | 2019-06-04 |
| WO2012019128A1 (en) | 2012-02-09 |
| EP3327032A1 (en) | 2018-05-30 |
| PT2601214T (pt) | 2017-12-20 |
| DK2601214T3 (en) | 2018-02-05 |
| US20130324465A1 (en) | 2013-12-05 |
| HRP20180154T1 (hr) | 2018-03-09 |
| SI2601214T1 (en) | 2018-03-30 |
| ES2652508T3 (es) | 2018-02-02 |
| US20160326501A1 (en) | 2016-11-10 |
| EP2601214B1 (en) | 2017-11-01 |
| PL2601214T3 (pl) | 2018-05-30 |
| CY1121111T1 (el) | 2019-12-11 |
| EP2601214A1 (en) | 2013-06-12 |
| US9441029B2 (en) | 2016-09-13 |
| HUE035554T2 (en) | 2018-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201209259B (en) | Uses and compositions | |
| IL225463A0 (en) | Preparations containing a tlr agonist and uses thereof | |
| GB201002983D0 (en) | Nutritinal composition | |
| GB201006200D0 (en) | Composition | |
| GB201006096D0 (en) | Novel compositions and uses thereof | |
| EP2552953A4 (en) | FRIZZLED-BINDING SUBSTANCES AND ITS USES | |
| EP2629742A4 (en) | HAIR CARE COMPOSITIONS AND RELATED METHODS | |
| EP2522643A4 (en) | CONCRETE COMPOSITION | |
| GB201113770D0 (en) | Novel compositions and uses thereof | |
| GB201006178D0 (en) | Composition | |
| GB2482365B (en) | Toner compositions and processes | |
| EP2874641A4 (en) | COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF | |
| IL219987A0 (en) | Dp2 antagonist and uses thereof | |
| HK1201451A1 (en) | Compositions and methods | |
| GB201018650D0 (en) | Methods and compositions | |
| ZA201206579B (en) | Endoparasiticidal compositions | |
| GB2483947B (en) | Toner compositions and processes | |
| LT2601214T (lt) | Vegf antagonistų kompozicijos ir jų panaudojimas | |
| EP2776064A4 (en) | ANTAGONISTS OF PRO-VASOPRESSIN AND USES THEREOF | |
| GB2478399B (en) | Toner compositions and methods | |
| GB201012848D0 (en) | Cement-containing compositions | |
| GB201006204D0 (en) | Composition | |
| GB201004717D0 (en) | Composition | |
| GB201006175D0 (en) | Composition | |
| GB201005826D0 (en) | New compositions and their use |